Transversal Research Programme in Adult Rare Diseases – REMMA Bellvitge

Rare diseases affect less than 1 in 2,000 people and are mostly genetic and heritable. They are chronic and complex diseases, compromising more than one organ and system, and can cause a variable degree of disability. In adult patients, the symptoms of a rare disease are less clear, which makes it harder and longer to diagnose and find an appropriate treatment. The REMMA transversal research program seeks to advance knowledge in adults’ rare diseases in order to improve medical response to these patients.

Thanks to the combination of basic research, clinical research and the transversal units of the Bellvitge Health Campus, at IDIBELL we work with an interprofessional approach, combining clinical, diagnostic, therapeutic and technical expertise, to treat and investigate more than 390 rare adult diseases of 16 different types: neurological, muscular, respiratory, cardiovascular, metabolic, ophthalmological, systemic and rheumatological, nephrological, digestive and biliopancreatic, and hereditary tumors, among others.